(Q51031213)
Statements
Multi-institutional phase I study of low-dose ultra-fractionated radiotherapy as a chemosensitizer for gemcitabine and erlotinib in patients with locally advanced or limited metastatic pancreatic cancer. (English)
1 reference
Andre Konski
1 reference
Joshua E Meyer
1 reference
Michael Joiner
1 reference
Michael J Hall
1 reference
Philip Philip
1 reference
Anthony Shields
1 reference
Erin McSpadden
1 reference
Minsig Choi
1 reference
Beth Adaire
1 reference
Gail Duncan
1 reference
Neal J Meropol
1 reference
Terrence P Cescon
1 reference
Steven J Cohen
1 reference
20 October 2014
1 reference
113
1 reference
1
1 reference
35-40
1 reference